SCHEMBL18895964

SCHEMBL18895964

CC(C)(O)C1C=CC2=C(C1)/C(=C/CCN1CC[C@@H](N3Cc4ccc(Cl)cc4C3)C1)C1=CC=CNC1CO2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13824455 0.92 — —
SCHEMBL14420022 0.80 — —
SCHEMBL10287625 0.78 — —
SCHEMBL13824457 0.76 BCHE (0.36) —
SCHEMBL14579858 0.75 — —
SCHEMBL13824459 0.65 CCR1 (0.40) —
SCHEMBL15478377 0.64 CCR1 (0.39) —
SCHEMBL13824448 0.64 CCR1 (0.61) —
SCHEMBL18896010 0.64 CCR1 (0.39) —
SCHEMBL13824447 0.64 CCR1 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9663537-B2 Chemokine receptor antagonists and methods of use MILLENNIUM PHARMACEUTICALS, INC. (US) 2017-05-30 — — US disclosed
Send feedback